Entreprise · 28/10/20261 min de lecture
MolecuLight Named Frost & Sullivan's 2026 Global Company of the Year in Wound Imaging
Traduction automatique locale · Langue originale de la source
Résumé
Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support PITTSBURGH, Oct.